Learn more: PMC Disclaimer | PMC Copyright Notice
Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells
Associated Data
Abstract
The small intestine contains CD4+CD8αα+ double-positive intraepithelial T lymphocytes (DP IELs), which originate from intestinal CD4+ T cells through downregulation of the transcription factor ThpoK and have regulatory functions. DP IELs are absent in germ-free mice, suggesting that their differentiation depends on microbial factors. We found that DP IEL numbers in mice varied in different vivaria, correlating with the presence of Lactobacillus reuteri. This species induced DP IELs in germ-free mice and conventionally-raised mice lacking these cells. L. reuteri did not shape DP-IEL-TCR repertoire, but generated indole derivatives of tryptophan that activated the aryl-hydrocarbon receptor in CD4+ T cells, allowing ThPOK downregulation and differentiation into DP IELs. Thus, L. reuteri together with a tryptophan-rich diet can reprogram intraepithelial CD4+ T cells into immunoregulatory T cells.
The gut microbiota drives maturation and function of the immune system (1–3). Several bacterial taxa shape the differentiation of naïve T cells: segmented filamentous bacteria (SFB) bias CD4+ T cells towards a Th17 fate (4), Clostridia clusters IV and XIVa promote CD4+ T regulatory cells (Treg) differentiation (5, 6); and Bacteroides fragilis (7, 8) and Faecalibacterium prausnitzii (9) induce CD4+ T cells that secrete IL-10. The small intestinal epithelium contains a unique population of CD4+CD8αα+ TCR αβ T cells (referred to as double-positive intraepithelial lymphocytes, or DP IELs) (10). These cells have a regulatory function complementary to that of Tregs and promote tolerance to dietary antigens (11). DP IELs originate from lamina propria CD4+ T cells that include but are not limited to Tregs (11). Upon reaching the epithelium, these cells reactivate the CD8+ T cell lineage program through downregulation of Thpok and upregulation of Runx3 and T-bet (12–14). This process is facilitated in part by transforming growth factor-β (TGFβ), retinoic acid (RA), IFN-γ and IL-27 (12, 14). The lack of DP IELs in germ-free (GF) mice (11, 13) indicates that the intestinal microbiota is required for their differentiation, although the bacterial taxa and metabolites required are not known.
We noticed that mice born at one of our vivaria [specialized research facility (SRF)] harbored substantial numbers of DP IELs (DP+), whereas DP IELs were negligible or absent (DP−) in mice from another vivarium [Clinical Sciences Research Building (CSRB)] (Fig. 1A). Moreover, DP IELs in SRF mice expressed low levels of the transcription factor Thpok, Thpoklo, whereas CSRB mice lacked CD4+ Thpoklo IELs (13), consistent with the observed lack of DP IELs (fig. S1). Thus, the microbiota in SRF mice might contain taxa capable of inducing DP IELs. Consistent with this, DP IELs appeared in CSRB mice after gavage with fecal or ileal microbiota from SRF, but not CSRB animals (Fig. 1B).
Most SRF (DP+) mice are embryo-rederived using female recipient mice from Charles River (CR) Laboratories and thus acquire a CR microbiota. In contrast, most CSRB (DP−) mice originate from the Jackson Laboratories (JAX). Thus, taxa present in CR but not JAX mice might induce DP IELs. Indeed, C57BL/6 mice purchased from CR had a DP+ phenotype, whereas C57BL/6 mice purchased from JAX had a DP− phenotype (Fig. 1C). DP+ and DP− phenotypes were vertically transmissible (Fig. 1D). Moreover, the DP+ phenotype was laterally transferable from CR to JAX mice by co-housing animals (Fig. 1E) or by colonizing JAX mice with CR-ileal or fecal microbiota (Fig. 1F). Treatment of CR mice with vancomycin, ampicillin, neomycin and metronidazole (VNAM) abrogated DP IELs (Fig. 1G), as did ampicillin and vancomycin only, which target Gram-positive bacteria; neomycin, which targets Gram-negative bacteria, led to a slight increase in DP IELs (Fig. 1H); metronidazole did not affect DP IELs. Thus, DP IELs are induced by neomycin-resistant Gram-positive bacterial taxa.
To define bacterial taxa that induce DP IELs, we sequenced PCR amplicons from 16S ribosomal RNA genes present in the ileum of CR and JAX mice, as well as neomycin-treated and untreated CR animals. Six operational taxonomic units (OTUs) were selectively present in the CR microbiota and were also present or enriched after neomycin treatment (fig. S2A). These OTUs included Lactobacillus reuteri and five members of the Bacteroidales S24-7 lineage (Fig. 2A, fig. S2A, and Table S1). L. reuteri was present in the ileum of CR control mice and CR mice treated with neomycin or metronidazole, but absent in CR mice treated with ampicillin plus vancomycin (fig. S2B).
Two L. reuteri strains (WU and 100-23) induced DP IELs after colonization of JAX mice (Fig. 2B), whereas L. johnsonii, L. murinus (Fig. 2C), and various Bacteroides species (Fig. 2D) did not. As expected, DP IELs were absent throughout the small intestine of GF animals (11, 13)(Fig. 2E). Concurrent inoculation of GF mice with L. reuteri (WU strain) and ileal microbiota from JAX mice induced DP IELs, whereas JAX ileal microbiota alone was ineffective (Fig. 2F). Mono-colonization with L. reuteri resulted in a slight increase of DP IELs. As expected, transfer of CR intestinal microbiota induced DP IELs. Thus, L. reuteri induces DP IELs, but the presence of other microbes enhances this effect perhaps by expanding the CD4+ T cells in the lamina propria and epithelium.
We next examined how L. reuteri induces DP IELs. If L. reuteri antigens shape the specificity of DP IELs, these cells would express quasi-clonal TCR αβ repertoires, as shown for SFB-specific Th17 cells (15). Analysis of TCR Vβ expression on DP IELs, CD4 IELs and mesenteric lymph node (MLN) naïve CD4+ T cells showed that TCR Vβ usage of DP IELs resembled that of CD4 IELs, but was different from that of naïve CD4+ T cells (Fig. 3A). In each mouse analyzed, DP IELs exhibited a preferential Vβ usage (> 2-fold compared to MLN), although no enrichment for a specific Vβ pattern was shared by all mice, suggesting mouse-to-mouse variability in DP IEL TCRs (Fig. 3A and B; and fig. S3A). Because the great diversity of polyclonal T cells complicates analysis at the individual TCR level, we analized the TCR α repertoires of DP IELs, CD4 IELs, CD8 IELs, and MLN naïve CD4+ T cells from mice that express a fixed transgenic TCR β chain (TCli+ mice) (16, 17). Tcli+ T cells were very similar in phenotype and frequency to WT T cells (fig. S3B). TCR Renyi diversity profiles showed both decreased diversity (lower entropy at each order) and evidence for increased clonal expansion (greater downward slope) in the repertoires of all three IEL subsets compared to the repertoire of naïve CD4+ T cells (fig. S3C). The TCR α repertoires of CD4 IELs, CD8 IELs, and DP IELs were distinct from those of naïve CD4+ T cells (Fig. 3C), consistent with the expansion of T cell clones in response to specific antigens. Moreover, the TCR α repertoires of DP IELs and CD4 IELs were similar, but distinct from those of CD8 IELs (Fig. 3D and E), corroborating that DP IELs differentiate from CD4 IELs. Although the TCR α repertoires of naïve T cells were similar in all mice analyzed, the TCR α repertoires of DP IELs and CD4 IELs were quite distinct in each mouse (Fig. 3F), suggesting that the specificity of CD4+ IELs and DP IELs is shaped by various environmental and/or self-antigens in each mouse, rather than by a single antigen.
Some bacterial taxa shape T cell differentiation via their physical components (e.g., polysaccharide A (7, 18)), or their metabolic products (e.g., short-chain fatty acids (19–21)). L. reuteri releases reuterin (22), and histamine (23), and also has the ability to metabolize tryptophan (L-Trp) to indole derivatives, some of which activate the aryl-hydrocarbon receptor (AhR) in group 3 innate lymphoid cells (ILC3s) (24, 25). Accordingly, culture supernatants of L. reuteri grown in L-Trp-containing medium activated an AhR reporter cell line, whereas supernatants from L. johnsonii or L. murinus did not (Fig. 4A). To determine whether L. reuteri induces DP IELs through the release of AhR ligands, we added L. reuteri culture supernatants to naïve ovalbumin-specific CD4+ T cells (OTII) stimulated with ovalbumin peptide-pulsed dendritic cells (DCs) with or without TGFβ (12). L. reuteri culture supernatant induced CD8αα+CD4+ T cell differentiation of OTII T cells, as did the AhR agonist 2,3,7,8-tetrachlorodibenzodioxin (TCDD) (Fig. 4B and fig. S4A) but only in the presence of TGFβ. The AhR antagonist CH223191 inhibited CD8αα+CD4+ T cell differentiation, confirming that the L. reuteri supernatant acts through AhR. AhR agonists plus TGFβ were as effective as TGFβ plus retinoic acid and IFN-γ (12, 14) (Fig. 4B). We also generated a strain of L. reuteri lacking a functional aromatic aminotransferase and hence the ability to convert amino acids into indolic AhR ligands (L. reuteri ΔArAT) (24, 26). Culture supernatants from L. reuteri ΔArAT failed to stimulate the AhR reporter cells (Fig. 4C). Moreover, L. reuteri ΔArAT did not induce DP IELs in JAX mice (Fig. 4D), although this strain colonized mice efficiently (fig. S4B).
We next assessed the impact of dietary L-Trp levels in DP IELs development. More DP IELs were observed in CR mice fed a high L-Trp diet (0.48%) than in mice fed standard (0.24%) or low (0.11%) L-Trp diets (Fig. 4E). However, a high L-Trp diet failed to induce DP IELs in germ-free mice mono-colonized with either L.reuteri 100-23 or L. reuteri ΔArAT (fig. S4C). Thus, L. reuteri acts together with a complex microbiota and dietary L-Trp to induce DP IELs. Bioactivity-guided fractionation of L. reuteri 100-23 supernatant identified the presence of indole-3-lactic (ILA) acid, an indole derivative of L-Trp, that activated the AhR reporter cell line and induced CD8αα+CD4+ T cells (fig. S5). This compound was as effective as indole-3-aldehyde (IAId), which activates AhR in ILC3s (24) (Fig. 4F and fig. S4D). AhR−/− mice lacked DP IELs, whereas these cells were present in Ahr+/− littermates and WT controls supporting our observation that L. reuteri induces DP IELs through the release of AhR ligands (Fig. 4G). We next asked whether AhR drives DP IEL differentiation in a T cell intrinsic or extrinsic fashion. TGFβ with either L. reuteri culture supernatant or TCDD induced CD8αα+CD4+ T cells from naïve WT CD4+ T cells stimulated in vitro with AhR−/− or WT splenic DCs pulsed with a combination of three superantigens. In contrast, AhR−/− T cells did not differentiate into CD8αα+CD4+ T cells, whether or not DCs lacked AhR, implying that AhR is required in T cells (Fig. 4H). Moreover, stimulation of OTII T cells with Ahr−/− or WT DCs in the presence of TGFβ and either L. reuteri supernatant or TCDD induced CD8αα+CD4+ T cells (fig. S4E). Finally, DP IELs were significantly reduced in Ahrfl/fl × Rorc-Cre mice (which lack AhR in T cells and ILCs), as well as in Ahrfl/fl × Cd4-Cre mice, (which lack AhR in T cells) in comparison to littermate controls (Fig. 4I, fig. S4 F and G), demonstrating that DP IEL-development requires AhR activation in T cells. To determine when AhR signaling intervenes in the DP IEL-developmental pathway, we analyzed the expression of Thpok in IELs from Ahr+/− and AhR−/− mice. Thpokhi CD8αα−CD4+ IELs, ThpoKlo CD8αα+CD4+ IELs (DP IELs) and a small intermediate population of ThpoKlo CD8αα−CD4+ IELs were evident in Ahr+/− mice, whereas a single Thpokhi CD4+ IEL population predominated in AhR−/− mice (Fig. 4J). Thus, lack of AhR signaling arrests DP IEL-development before Thpok downregulation occurs.
Our study reveals that L. reuteri provides indole-derivatives of dietary L-Trp, such as indole-3-lactic acid, that activate AhR and lead to downregulation of Thpok and reprogramming of CD4+ IELs into DP IELs. Other indole derivatives may have a similar effect. This Ahr-mediated mechanism is distinct from those by which AhR impacts other T cells with regulatory functions (Tr1, Tregs), intraepithelial γδ T cells and DCs (27–32). Yet undefined microbial species, dietary and/or self-antigens are necessary to expand the CD4+ IEL population with a diverse TCR repertoire that converts into DP IELs. The complete reliance of DP IELs on a single species, L. reuteri, and its tryptophan metabolites for their final maturation may provide a basis for the use of L. reuteri as a probiotic and tryptophan-rich food to treat disorders that may be modifiable by DP IELs, such as inflammatory bowel diseases (11).
Supplementary Material
Figs. S1 to S7, Tables S1, S2, S4 and S5. Caption for table S3 and S6
Supp. Table 3
Supp. Table 6
Acknowledgments
We want to thank Maria Karlsson and David O'Donell for their assistance in the gnotobiotic facility and Jessica Hoisington-Lopez from the DNA Sequencing Innovation Lab at The Edison Family Center for Genome Sciences and Systems Biology for her sequencing expertise. We thank members of our laboratory, in particular Jennifer Bando, for her suggestions and critical reading of this manuscript. This work was supported by the Rainin foundation, U01 AI095542 and DK103039 (M. Colonna), RO1-DK094995 and Burroughs Wellcome Fund (C.S. Hsieh), RO1 CA176695 (M. Cella), DK30292 (J.I. Gordon), and NIH Director’s New Innovator Award ID: 1DP2AI124441 (M.S. Donia). P.P.Ahern is the recipient of a Sir Henry Wellcome Postdoctoral fellowship (096100). L. Cervantes-Barragan was supported by Swiss National Science Foundation (fellowship PBSKP3-134332) and the Swiss Foundation for Medical-Biological Grants (fellowship PASMP3-145751).
Footnotes
The data reported in this manuscript are presented in the main paper and in the supplementary materials.